Edges in Network
| Network | GSE25065_top8000 - GSE25065 - SiGN-BN NNSR |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | LY96 |
| Upstream (Parents) |
|---|
| (<<) SAMSN1 → LY96 |
| (<<) EVI2B///EVI2A → LY96 |
| (<<) CLEC2B → LY96 |
| Downstream (Children) |
|---|
| LY96 → SAMHD1 (>>) |
| LY96 → C3AR1 (>>) |
| LY96 → FLJ22184 (>>) |
| LY96 → SAT1 (>>) |
| LY96 → IFNAR2 (>>) |
| LY96 → SAMSN1 (>>) |
| LY96 → GLRX (>>) |
| LY96 → LMO2 (>>) |
| LY96 → HLA-DRB4 (>>) |
| LY96 → LOC728855 (>>) |
| LY96 → NPL (>>) |
| LY96 → PLXNB1 (>>) |
| LY96 → OBFC2A (>>) |
| LY96 → RRP12 (>>) |
| LY96 → KCTD12 (>>) |
| LY96 → FCGR2B (>>) |
| LY96 → PTGER2 (>>) |
| LY96 → PTGER4 (>>) |
| LY96 → TACC1 (>>) |
| LY96 → GLIPR1 (>>) |
| LY96 → ZEB2 (>>) |
| LY96 → CLEC7A (>>) |
| LY96 → HIP1R (>>) |
| LY96 → MARCH1 (>>) |
| LY96 → ARHGAP33 (>>) |
| LY96 → DAB2 (>>) |
| LY96 → CLEC2B (>>) |
| LY96 → ACSL1 (>>) |
| LY96 → BRSK2 (>>) |
| LY96 → CASP1 (>>) |
| LY96 → APOA1 (>>) |
| LY96 → TSGA10 (>>) |
